Package 55150-326-01

Brand: clofarabine

Generic: clofarabine
NDC Package

Package Facts

Identity

Package NDC 55150-326-01
Digits Only 5515032601
Product NDC 55150-326
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (55150-326-01) / 20 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2022-10-03
Brand clofarabine
Generic clofarabine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "18adf4af-63ed-41e6-ab59-87085ce3e5fb", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0355150326013"], "unii": ["762RDY0Y2H"], "rxcui": ["486419"], "spl_set_id": ["18adf4af-63ed-41e6-ab59-87085ce3e5fb"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55150-326-01)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-326-01", "marketing_start_date": "20221003"}], "brand_name": "CLOFARABINE", "product_id": "55150-326_18adf4af-63ed-41e6-ab59-87085ce3e5fb", "dosage_form": "INJECTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "55150-326", "generic_name": "CLOFARABINE", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CLOFARABINE", "active_ingredients": [{"name": "CLOFARABINE", "strength": "1 mg/mL"}], "application_number": "ANDA212457", "marketing_category": "ANDA", "marketing_start_date": "20221003", "listing_expiration_date": "20261231"}